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A 55;year-old white male with a diagnosis of acquired 
immunodeficiency syndrome (AIDS), based on a low CD4 
count, for more than 3 years presented with a 3-week 
history of fever, drenching sweats, and a IO-pound weight 
loss. He denied rigors, headache, diarrhea, abdominal pain, 
visual changes, cough, dyspnea, or rash. The fevers were 
of gradual onset and reached 40°C on several occasions. 
Despite fevers, he was fully ambulatory and able to carry 
out his daily activities. 
The patient lived in Hawaii and had travelled exten- 
sively on business during the previous 2 years, to the 
Philippines, Indonesia (Jakarta), Peru, and northern Thai- 
land. His most recent travel was to the Philippines 4 
months prior to his presentation. There was no history 
of animal exposure. He had taken appropriate prophy- 
laxis for travel in malarial areas. 
He had no prior opportunistic infections or hospi- 
talizations. A CD4 count was 3O/p,L. He was PPD negative 
and had no known tuberculosis exposure. Granulocyte 
colony stimulating factor had been administered inter- 
mittently for 3 months prior to presentation for neu- 
tropenia. A bone marrow examination had not been 
performed. Other medications included stavudine, lamivu- 
dine, rifabutin, and trimethoprim/sulfamethoxazole. 
On admission for neutropenia and fever, the patient 
appeared well nourished and in no distress. His temper- 
ature was 40°C the heart rate was 100 bpm, the respi- 
rations were 18 per minute, and blood pressure was 
1 lo/64 mmHg. Physical examination was remarkable only 
for hepatosplenomegaly. There was no adenopathy, 
abdominal tenderness, or skin rash. 
Laboratory examination was significant for pancyto- 
penia, with a hematocrit of 23.9% and a white cell count 
of 500/mm3 with 65% granulocytes, 12% bands, 24% lym- 
phocytes, and 1% monocytes. Platelets were 65,000/mm3. 
Liver function test results were slightly elevated; the 
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alkaline phosphatase was 323 U/L, serum aspartate amino- 
transferase 91 U/L, and the lactic dehydrogenase 348 U/L. 
The urine was normal, as were electrolytes, glucose, cre- 
atinine, and chest x-ray. 
Differential diagnosis on admission included histo- 
plasmosis, typhoid fever, disseminated Mycobacterium 
avium complex, tuberculosis, Penicillium marneffei 
infection, leishmaniasis, and malaria. Lymphoma was the 
primary noninfectious etiology considered. 
The clinical picture was consistent with histoplas- 
mosis, but the normal lactic dehydrogenase and the lack 
of travel to a highly endemic area militated against this 
diagnosis. Mycobacterial infection, especially M. avium 
complex infection, was strongly considered, even though 
the patient was on rifabutin prophylaxis, in view of the 
high fever, weight loss, pancytopenia, hepatospleno- 
megaly, and elevated alkaline phosphatase. The travel to 
northern Thailand suggested possible infection with l? 
mameffei despite the lack of skin lesions and presence 
of pancytopenia. The patient’s symptoms were also con- 
sistent with disseminated leishmaniasis; however he did 
not have exposure risk to the usual species causing this 
condition. Malaria was considered, but pancytopenia, the 
normal lactic dehydrogenase and bilirubin, and a history 
of appropriate malaria prophylaxis made this diagnosis 
less likely. Typhoid fever was unlikely, because there was 
no recent travel, although several aspects of his presen- 
tation were compatible, including fever, pancytopenia, 
and hepatosplenomegaly. Lastly, the presentation was also 
suggestive of an AIDS-related lymphoma; however, the 
lack of adenopathy and normal lactic dehydrogenase were 
not supportive of this diagnosis. 
Blood cultures were obtained for bacteria, fungi, and 
mycobacteria, and the patient received broad-spectrum 
antibiotics for neutropenic fever. Blood smears were neg- 
ative for malaria, and stool specimens for culture and par- 
asites were negative. Abdominal computed tomography 
(CT) showed only hepatosplenomegaly. 
Bone marrow biopsy and aspirate revealed a bone 
marrow packed with aggregates of histiocytes parasitized 
by large numbers of fungal organisms (Figure 1). The 
morphology was initially thought to be suggestive of 
histoplasmosis. A bone marrow specimen sent for myco- 
logic culture was plated onto Sabouraud dextrose and 
brain-heart infusion (BHI) agars. Shrink seals were affixed 
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Figure 1. Bone marrow reveals aggregates of histiocytes parasitized 
by large numbers of fungal organisms. 
to the plates, after which they were incubated at 30°C in 
ambient air. After 48 hours of incubation, the develop- 
ment of small colonies of whitish mold-like growth was 
observed. After 72 hours the colony assumed a greyish 
tinge and was seen to produce a red diffusible pigment 
(Figure 2). A lactophenol cotton blue tease preparation 
of this growth revealed the presence of septate hyphae 
containing conidiophores that exhibited a penicillus or 
brush-like structure (Figure 3). After 4 days the colony 
appeared blue-green and eventually turned golden yel- 
low with age. A presumptive identification of P mamef- 
fei was made, based on the morphologic characteristics 
of the organisms and the clinical presentation. 
To confirm the identification, a subculture of this fun- 
gus was placed into BHI broth and incubated at 37°C in 
ambient air. Microscopic examination of a lactophenol 
cotton blue preparation of the resulting growth showed 
the presence of round to oval yeast-like cells, some of 
which contained central cross walls typical of an organ- 
Figure 2. After 72 hours the colony assumed a greyish tinge and 
produced a diffuse red pigment. 
ism that reproduces by fission instead of by budding. The 
thermal conversion of this fungus to a yeast-like phase at 
37°C confirmed the identification of this isolate as Pmam- 
effei. Blood cultures were also positive for the organism. 
The patient was treated with amphotericin B, 
30 mg/day for 14 days, but was without fever after day 
4. He did not require granulocyte stimulating factor, 
although his granulocyte count remained low. His platelet 
count rose to normal by the 14th day He was discharged 
on 400 mg itraconozole per day for maintenance ther- 
apy and remained well 5 months after discharge. 
DISCUSSION 
Penicillium marneffei is the only thermal dimorphic 
pathogenic species in the genus Penicillium. It is found 
in tissue as yeast-like cells, but forms a distinctive red pig- 
mented mold colony on agar. It was first isolated in Viet- 
nam, in 1956. The natural reservoirs of this fungus are 
four species of bamboo rats, Rhizomys sumatrensis, Rhi- 
zomys pruinosus, Rhizomys sinensis, and Cannomys 
bad&s, and it has been found in soil samples of their 
burrows.’ Infection is thought to be acquired by inhala- 
tion of spores, and evidence of both symptomatic pri- 
mary and reactivation of latent infection have been 
described, primarily in immunosuppressed hosts. 
This fungus is endemic in Thailand, southern China, 
Hong Kong, Vietnam, and Indonesia. Incidence of this 
infection has increased substantially in recent years, 
almost exclusively in persons with human immunodefi- 
ciency virus (HIV) infection. It is the third most common 
opportunistic infection in this group in northern Thai- 
land, exceeded only by tuberculosis and cryptococcosis.’ 
Clinical manifestations include fever; weight loss; skin 
lesions, which are most often a generalized papular rash 
with or without umbilication; cough; and diarrhea. Lym- 
phadenopathy and hepatomegaly are found in over half 
of the patients. Laboratory abnormalities may include an 
abnormal chest x-ray, elevated liver function tests, and 
anemia. The mean CD4 count at diagnosis in adults in 
one series was ~/FL.~ In children, infection also is found 
in those with advanced HIV disease.3 
A presumptive diagnosis of I! marnefii can be made 
by microscopic examination of bone marrow, skin biopsy, 
and lymph node biopsy. Definitive diagnosis requires cul- 
ture of the fungus from clinical specimens. Bone marrow, 
skin, lymph node, and blood cultures have the highest 
yield. Cultures of cerebrospinal fluid, sputum, pleural fluid, 
and liver biopsy have also yielded the organism. In the 
present case, the extent of marrow involvement seen on 
microscopic examination was extraordinary 
Data on the in vitro susceptibility of l? marneffei to 
antifungal agents indicate that it is highly susceptible to 
micronazole, itraconazole, ketoconazole, and 5-fluoro- 
cytosine. Amphotericin B showed intermediate antifungal 
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survival. If left untreated, mortality due to this infection is 
100% in persons with AIDS. 
A thorough travel history assists in making the diag- 
nosis in AIDS patients not living in an endemic area for 
P mameffei. Because it is easy to confuse the spores of 
Histoplasma capsulatum and P marneffei in clinical 
specimens, careful attention must be paid to the mor- 
phology of the Giemsa-stained organisms. 
As the AIDS epidemic spreads across endemic and 
suspected endemic areas for l? mameffei, this organism 
has become an important emerging pathogen. It should 
be regarded as another AIDS-defining infection. 
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